Articles From: Cloud Sherpas Predicts Massive Growth for ServiceNow Business Unit to CME Group Announces New Futures Contracts for Renewable Identification Numbers (RINs)


2013/5/15
http://media.marketwire.com/attachments/201212/113757_cloud_sherpas_logo-250px.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1017645&ProfileId=051205&sourceType=1 ATLANTA, GA --
Sign-up for Cloud Sherpas Predicts Massive Growth for ServiceNow Business Unit investment picks
2013/4/18
NEWPORT BEACH, Calif.
Sign-up for Cloud Star Corp Announces App Secure™ Technology investment picks
2013/3/27
NEWPORT BEACH, Calif.
Sign-up for Cloud Star Corp Announces Joint Venture and Purchase Option with App Ventures Ltd. investment picks
2013/5/28
NEWPORT BEACH, Calif.
Sign-up for Cloud Star Corp Announces Name Change To Cloud Security Corporation investment picks
2013/3/6
NEWPORT BEACH, Calif.
Sign-up for Cloud Star Corp Attends The RSA Conference in San Francisco investment picks
2013/4/2
NEWPORT BEACH, Calif.
Sign-up for Cloud Star Corp Hires Chief Technology Advisor investment picks
2013/5/22
NEWPORT BEACH, Calif.
Sign-up for Cloud Star Corp Joins the FIDO Fast Identity Online Alliance investment picks
2013/5/1
NEWPORT BEACH, Calif.
Sign-up for Cloud Star Corp Receives $350,000 of Funding From Investor investment picks
2013/1/30
Red Hat, Inc. (NYSE: RHT) , the world’s leading provider of open source solutions, today announced that Cloud9 IDE has built its online development environment with Red Hat’s OpenShift Online hosted Platform-as-a-Service (PaaS) solution.
Sign-up for Cloud9 IDE Builds Online Development Environment with Red Hat OpenShift investment picks
2013/6/5
http://media.marketwire.com/attachments/201304/145732_cloudmeter-logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1023872&ProfileId=051205&sourceType=1 MOUNTAIN VIEW, CA --
Sign-up for Cloudmeter Stream for Splunk Enterprise Now Available for Download on Splunkbase investment picks
2013/2/28
Clovis Oncology , Inc. (NASDAQ:CLVS) today reported financial results for its quarter and year ended December 31, 2012, and provided an update on the expected milestones for its clinical development programs for 2013.
Sign-up for Clovis Oncology Announces 2012 Operating Results and 2013 Objectives investment picks
2013/5/16
Clovis Oncology (NASDAQ:CLVS) announced that three abstracts (ASCO Abstracts #2524, #2585, #2586) highlighting results from three Phase I studies of the company’s two lead compounds will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2013 in Chicago.
Sign-up for Clovis Oncology Announces Clinical Data to be Presented at ASCO Annual Meeting 2013 investment picks
2013/5/7
Clovis Oncology , Inc. (NASDAQ:CLVS) today reported financial results for its first quarter ended March 31, 2013, and provided an update for its clinical development programs .
Sign-up for Clovis Oncology Announces First Quarter 2013 Operating Results investment picks
2013/4/23
Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its first quarter 2013 financial results on Tuesday, May 7, 2013, before the open of the U.S. financial markets.
Sign-up for Clovis Oncology to Announce First Quarter 2013 Financial Results and Host Webcast Conference Call on May 7 investment picks
2013/2/14
Clovis Oncology, Inc. (NASDAQ:CLVS) will announce its fourth quarter/year end 2012 financial results on Thursday, February 28, 2013, after the close of the U.S. financial markets.
Sign-up for Clovis Oncology to Announce Fourth Quarter/Year End 2012 Financial Results and Host Webcast Conference Call on February 28 investment picks
2013/5/8
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Erle T.
Sign-up for Clovis Oncology to Present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas investment picks
2013/2/25
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J.
Sign-up for Clovis Oncology to Present at the Cowen Health Care Conference in Boston investment picks
2013/6/3
Clovis Oncology (NASDAQ:CLVS) today announced initial findings from the Phase I portion of its ongoing Phase I/II clinical study of CO-1686, the Company’s novel, oral, targeted covalent (irreversible) inhibitor of mutant forms of the epidermal growth factor receptor (EGFR) for the treatment of non-small cell lung cancer (NSCLC) in patients with initial activating EGFR mutations as well as the dominant resistance mutation T790M.
Sign-up for Clovis Oncology’s CO-1686 Demonstrates Encouraging Results from Ongoing Phase I/II Study in EGFR-mutant Non-Small Cell Lung Cancer investment picks
2013/6/3
Clovis Oncology (NASDAQ:CLVS) today announced initial findings from an ongoing Phase I/II monotherapy study of rucaparib, the Company’s oral, potent, small molecule poly (ADP-ribose) polymerase (PARP) inhibitor being developed for the treatment of ovarian cancer.
Sign-up for Clovis Oncology’s Rucaparib Demonstrates Encouraging Results from Ongoing Phase I/II Monotherapy Study in Patients with Solid Tumors investment picks
2013/5/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0875204001&sourceType=1 http://www.ccnmatthews.com/logos/20100330-club200.jpg KING CITY, ONTARIO --
Sign-up for ClubLink Enterprises Limited Announces Election of Directors investment picks
2013/5/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0873097001&sourceType=1 http://www.ccnmatthews.com/logos/20100330-club200.jpg KING CITY, ONTARIO --
Sign-up for ClubLink Enterprises Limited Announces First Quarter 2013 Results and Eligible Dividend investment picks
2013/3/18
LONDON , March 18, 2013 /PRNewswire/ -- CME Clearing Europe , CME Group's European clearing house, today announced that it has received FSA approval and launched real-time, open access clearing of Interest Rate Swaps (IRS). This is the first step in CME Clearing Europe's expansion into clearing Over the Counter (OTC) financial derivatives and adds to what CME Group already has accomplished with clearing OTC IRS in the US and CME Clearing Europe's existing energy and commodity business line.
Sign-up for CME Clearing Europe Expands Services with Introduction of Interest Rate Swaps investment picks
2013/4/25
CHICAGO --
Sign-up for CME Declares Force Majeure at Illinois River Terminals Due to Floods investment picks
2013/5/2
CME Group Inc.'s (CME) first-quarter earnings fell 12%, hurt by a decline in trading fees.
Sign-up for CME Group 1Q Profit Falls 12%, Revenue Off 7%; Trading Fees Slip investment picks
2013/3/25
CHICAGO , March 25, 2013 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced the winners of the 2013 Commodity Trading Challenge .
Sign-up for CME Group Announces Commodity Trading Challenge Winners investment picks
2013/4/10
Short-Dated New Crop Options Combined Open Interest Surpasses 100k CHICAGO , April 10, 2013 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, announced it reached a daily volume record for its Short-Dated New Crop Corn options on Monday, April 8 .
Sign-up for CME Group Announces Daily Volume Record in Short-Dated New Crop Corn Options investment picks
2013/5/17
NEW YORK , May 17, 2013 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced the first Ethanol Renewable Identification Number (RINs) futures contract was cleared yesterday over CME ClearPort.
Sign-up for CME Group Announces First Trade of Ethanol RINs Futures investment picks
2013/4/16
Overall Metals Complex, Gold Futures, Gold Options and Copper Futures Set New Daily Volume Records CHICAGO , April 16, 2013 /PRNewswire/ --  CME Group , the world's leading and most diverse derivatives marketplace, today announced that yesterday it reached multiple daily trading volume records across its metals complex, including a combined futures and options volume increase of 78 percent for its Metals Products asset class.
Sign-up for CME Group Announces Multiple Trading Volume Records Across Metals Complex investment picks
2013/4/25
NEW YORK , April 25, 2013 /PRNewswire/ --  CME Group , the world's leading and most diverse derivatives marketplace, today announced the launch of nine new futures contracts for Renewable Identification Numbers (RINs). These contracts will be listed with, and subject to, the rules and regulations of NYMEX.
Sign-up for CME Group Announces New Futures Contracts for Renewable Identification Numbers (RINs) investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cloud Sherpas Predicts Massive Growth for ServiceNow Business Unit to CME Group Announces New Futures Contracts for Renewable Identification Numbers (RINs)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity